- Cal-Maine’s Earnings Per Share (EPS) for the fourth quarter was $7.04, a significant increase from last year’s $2.32, and surpassed the analyst estimate of $6.27.
- Net sales for Cal-Maine reached $1.10 billion, representing a 72% increase compared to the previous year and exceeding the estimated $965.3 million.
- The company sold 311.39 million dozen eggs, marking a 9% year-over-year growth.
- The net average selling price per dozen eggs was $3.305, up by 55% compared to the previous year.
- Cal-Maine’s financial success is attributed to its adaptability to the dynamic market, as stated by Max Bowman, the vice president and chief financial officer.
- Analyst recommendations for Cal-Maine include 1 buy and 2 holds, with no sell ratings.
A look at Cal Maine Foods Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 5 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Cal-Maine Foods, Inc. is poised for a positive long-term outlook based on the Smartkarma Smart Scores. With top rankings in Dividend, Growth, Resilience, and Momentum, the company demonstrates strong fundamentals across multiple key factors. This indicates a robust foundation for future success in the fresh shell egg market.
Cal-Maine Foods’ impressive scores, particularly in Dividend, Growth, Resilience, and Momentum, underscore its potential for sustained growth and stability. As a leading producer and seller of fresh shell eggs in various regions of the United States, the company’s solid performance across these key areas signals a promising trajectory for long-term success and value creation for investors.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
